Exelixis | Zobowiązania Handlowe



Trade Creditors Zmiana Data
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.54B 79M 2025-03
Bayer EUR 7.52B 957M 2024-12
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Cytokinetics USD 20.37M 8.79M 2024-12
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Exelixis USD 38.19M 21.12M 2025-01
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
MacroGenics USD 5.01M 1.6M 2024-12
Merck USD 4.08B 493M 2024-12
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Sanofi 7.55B 118M 2024-12
Takeda JPY 460.18B 46.85B 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Xencor USD 16.76M 2.01M 2024-12



Exelixis Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.